| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,778 |
19,736 |
$919K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
9,705 |
8,484 |
$379K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,987 |
4,332 |
$249K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14,493 |
12,614 |
$194K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,152 |
2,048 |
$171K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,192 |
2,053 |
$167K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,629 |
1,560 |
$138K |
| S8301 |
Infection control supplies, not otherwise specified |
7,374 |
6,251 |
$138K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,814 |
4,062 |
$118K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,345 |
1,287 |
$99K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,089 |
4,256 |
$98K |
| 99429 |
|
1,335 |
1,306 |
$45K |
| 99000 |
|
2,302 |
2,126 |
$22K |
| 92558 |
|
3,534 |
3,426 |
$21K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,081 |
1,603 |
$17K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
271 |
262 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,124 |
900 |
$14K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,142 |
1,084 |
$13K |
| 90461 |
|
2,475 |
2,053 |
$10K |
| 87807 |
|
761 |
700 |
$8K |
| 92550 |
|
216 |
211 |
$4K |
| 99050 |
|
296 |
284 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
66 |
64 |
$3K |
| 0001A |
|
86 |
82 |
$3K |
| 96160 |
|
1,571 |
1,503 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
93 |
93 |
$3K |
| 0072A |
|
66 |
66 |
$3K |
| 97169 |
|
75 |
72 |
$3K |
| 0071A |
|
62 |
61 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
30 |
30 |
$2K |
| 0002A |
|
53 |
52 |
$2K |
| 86328 |
|
50 |
47 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
751 |
577 |
$1K |
| 0003A |
|
30 |
30 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
14 |
14 |
$1K |
| 90620 |
|
114 |
110 |
$443.04 |
| 92552 |
|
48 |
42 |
$417.63 |
| 83655 |
|
32 |
30 |
$305.10 |
| 81003 |
|
119 |
114 |
$215.10 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
15 |
$212.49 |
| 99051 |
|
68 |
65 |
$209.16 |
| 90686 |
|
769 |
751 |
$118.21 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
4,077 |
3,948 |
$60.00 |
| 85018 |
|
19 |
17 |
$31.84 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
127 |
121 |
$27.25 |
| 85014 |
|
12 |
12 |
$23.88 |
| 90688 |
|
206 |
204 |
$17.36 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
14 |
$0.70 |
| 90651 |
|
453 |
432 |
$0.43 |
| 90677 |
|
310 |
298 |
$0.36 |
| 90671 |
|
240 |
234 |
$0.18 |
| 90656 |
|
509 |
505 |
$0.01 |
| 90670 |
|
628 |
621 |
$0.01 |
| 90680 |
|
686 |
671 |
$0.00 |
| 90647 |
|
292 |
289 |
$0.00 |
| 90697 |
|
487 |
470 |
$0.00 |
| 90723 |
|
282 |
279 |
$0.00 |
| 90696 |
|
73 |
73 |
$0.00 |
| 91307 |
|
12 |
12 |
$0.00 |
| 90734 |
|
353 |
339 |
$0.00 |
| 99173 |
|
3,859 |
3,721 |
$0.00 |
| 90380 |
|
15 |
15 |
$0.00 |
| 90633 |
|
472 |
467 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
190 |
129 |
$0.00 |
| 90710 |
|
333 |
329 |
$0.00 |
| 90715 |
|
87 |
79 |
$0.00 |
| 90700 |
|
71 |
71 |
$0.00 |
| 90672 |
|
28 |
28 |
$0.00 |